Ginkgo Bioworks Share Price Today
(NASDAQ: DNA)

Name: Ginkgo Bioworks Share Price Today (NASDAQ: DNA) - Ginkgo Bioworks Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Ginkgo Bioworks share price is $7.27 & ₹625.10 as on 21 Mar 2025, 09.30 hrs IST

$7.27

▲

0.1

(1.39%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Ginkgo Bioworks share price in Dollar and Rupees. Guide to invest in Ginkgo Bioworks stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ginkgo Bioworks, along with analyst recommendations, forecasts, and comprehensive financials.

Ginkgo Bioworks share price movements

Today's Low: $6.93
Today's High: $7.37
$7.27
4.68%
Downside
Day's Volatility :5.91%
Upside
1.29%
52 Weeks Low: $5.26
52 Weeks High: $48.00
$7.27
27.65%
Downside
52 Weeks Volatility :89.04%
Upside
84.85%

Ginkgo Bioworks (DNA) Returns

Period	Ginkgo Bioworks Holdings Inc	Sector (Materials)	Index (Russel 2000)
3 Months	-23.15%	0.8%	0.0%
6 Months	-7.15%	-9.2%	0.0%
1 Year	-83.33%	-6.1%	0.0%
3 Years	-95.11%	-0.9%	-13.8%

Ginkgo Bioworks (DNA) Key Statistics

in dollars & INR

Previous Close	$7.17
Open	$7.0
Today's High	$7.365
Today's Low	$6.9296
Market Capitalization	$416.1M
Today's Volume	$1.8M
52 Week High	$48.0
52 Week Low	$5.26
Revenue TTM	$227.0M
EBITDA	$-415.7M
Earnings Per Share (EPS)	$-10.54
Profit Margin	-240.94%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-60.34%

How to invest in Ginkgo Bioworks Stock (DNA) from India?

It is very easy for Indian residents to invest directly in Ginkgo Bioworks from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ginkgo Bioworks stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ginkgo Bioworks or DNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ginkgo Bioworks or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ginkgo Bioworks shares which would translate to 0.118 fractional shares of Ginkgo Bioworks as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ginkgo Bioworks, in just a few clicks!

Returns in Ginkgo Bioworks (DNA) for Indian investors in Rupees

The Ginkgo Bioworks stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Ginkgo Bioworks investment value today

Current value as on today

₹19,868

Returns

₹80,132

(-80.13%)

Returns from Ginkgo Bioworks Stock

₹83,326 (-83.33%)

Dollar Returns

₹3,194 (+3.19%)

Indian investors sentiment towards Ginkgo Bioworks (DNA)

-39.49%

Period: Feb 20, 2025 to Mar 22, 2025. Change in 30 Days versus previous period

Investment in Ginkgo Bioworks Shares from India has dropped by -39.49% over the past 30 days, indicating reduced transactional activity.

-67%

Period: Feb 20, 2025 to Mar 22, 2025. Change in 30 Days versus previous period

Search interest for Ginkgo Bioworks Stock from India on INDmoney has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ginkgo Bioworks

Bank of America Corp
6.49%
Viking Global Investors LP
6.16%
Baillie Gifford & Co Limited.
5.79%
Vanguard Group Inc
3.47%
Anchorage Advisors, LLC
3.01%
EcoR1 Capital, LLC
3.00%

Analyst Recommendation on Ginkgo Bioworks

Sell

7%Buy

42%Hold

50%Sell

Based on 14 Wall street analysts offering stock ratings for Ginkgo Bioworks(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ginkgo Bioworks Stock (DNA)

What analysts predicted

Upside of 18.29%

Target:

$8.60

Current:

$7.27

Insights on Ginkgo Bioworks Stock (Ticker Symbol: DNA)

Price Movement
In the last 1 month, DNA stock has moved down by -32.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 89.04M → 43.84M (in $), with an average decrease of 50.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -56.40M → -107.53M (in $), with an average decrease of 90.7% per quarter
DNA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 93.4% return, outperforming this stock by 176.4%
DNA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 74.5% return, outperforming this stock by 169.3%
Price to Sales
ForDNA every $1 of sales, investors are willing to pay $1.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.1 for every $1 of sales.

DNA Ginkgo Bioworks Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$54.2M	-
Net Income	$-119.3M	-
Net Profit Margin	-220.23%	-

	FY20	Y/Y Change
Revenue	$76.7M	↑ 41.48%
Net Income	$-126.6M	↑ 6.1%
Net Profit Margin	-165.16%	↑ 55.07%

	FY21	Y/Y Change
Revenue	$313.8M	↑ 309.4%
Net Income	$-1.8B	↑ 1350.64%
Net Profit Margin	-585.22%	↓ 420.06%

	FY22	Y/Y Change
Revenue	$477.7M	↑ 52.21%
Net Income	$-2.1B	↑ 14.61%
Net Profit Margin	-440.63%	↑ 144.59%

	FY23	Y/Y Change
Revenue	$251.5M	↓ 47.36%
Net Income	$-892.9M	↓ 57.58%
Net Profit Margin	-355.08%	↑ 85.55%

	FY24	Y/Y Change
Revenue	$227.0M	↓ 9.71%
Net Income	$-547.0M	↓ 38.73%
Net Profit Margin	-240.94%	↑ 114.14%

	Q3 FY23	Q/Q Change
Revenue	$55.4M	↓ 31.2%
Net Income	$-302.9M	↑ 74.76%
Net Profit Margin	-546.44%	↓ 331.32%

	Q4 FY23	Q/Q Change
Revenue	$34.8M	↓ 37.3%
Net Income	$-211.7M	↓ 30.11%
Net Profit Margin	-609.1%	↓ 62.66%

	Q1 FY24	Q/Q Change
Revenue	$37.9M	↑ 9.18%
Net Income	$-165.9M	↓ 21.63%
Net Profit Margin	-437.25%	↑ 171.85%

	Q2 FY24	Q/Q Change
Revenue	$56.2M	↑ 48.13%
Net Income	$-217.2M	↑ 30.9%
Net Profit Margin	-386.4%	↑ 50.85%

	Q3 FY24	Q/Q Change
Revenue	$89.0M	↑ 58.43%
Net Income	$-56.4M	↓ 74.03%
Net Profit Margin	-63.34%	↑ 323.06%

	Q4 FY24	Q/Q Change
Revenue	$43.8M	↓ 50.76%
Net Income	$-107.5M	↑ 90.65%
Net Profit Margin	-245.25%	↓ 181.91%

	FY19	Y/Y Change
Profit	$54.2M	-

	FY20	Y/Y Change
Profit	$61.0M	↑ 12.66%

	FY21	Y/Y Change
Profit	$184.1M	↑ 201.65%

	FY22	Y/Y Change
Profit	$273.5M	↑ 48.52%

	FY23	Y/Y Change
Profit	$197.5M	↓ 27.8%

	FY24	Y/Y Change
Profit	$188.5M	↓ 4.54%

	Q3 FY23	Q/Q Change
Profit	$48.5M	↓ 22.35%

	Q4 FY23	Q/Q Change
Profit	$18.8M	↓ 61.23%

	Q1 FY24	Q/Q Change
Profit	$15.9M	↓ 15.6%

	Q2 FY24	Q/Q Change
Profit	$25.2M	↑ 58.48%

	Q3 FY24	Q/Q Change
Profit	$79.1M	↑ 214.29%

	Q4 FY24	Q/Q Change
Profit	$34.2M	↓ 56.71%

	FY19	Y/Y Change
Operating Cash Flow	$-44.7M	-
Investing Cash Flow	$-74.6M	-
Financing Cash Flow	$410.4M	-

	FY20	Y/Y Change
Operating Cash Flow	$-135.8M	↑ 204.12%
Investing Cash Flow	$-67.1M	↓ 10.03%
Financing Cash Flow	$90.3M	↓ 77.99%

	FY21	Y/Y Change
Operating Cash Flow	$-253.8M	↑ 86.86%
Investing Cash Flow	$-73.3M	↑ 9.14%
Financing Cash Flow	$1.5B	↑ 1598.6%

	FY22	Y/Y Change
Operating Cash Flow	$-252.2M	↓ 0.64%
Investing Cash Flow	$-67.4M	↓ 8.0%
Financing Cash Flow	$95.3M	↓ 93.79%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-73.6M	↑ 0.02%
Investing Cash Flow	$-34.0M	↑ 11.04%
Financing Cash Flow	$-315.0K	↓ 77.19%

Ginkgo Bioworks Technicals Summary

Sell

Neutral

Buy

Ginkgo Bioworks is currently in a neutral trading position according to technical analysis indicators.

Ginkgo Bioworks (DNA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ginkgo Bioworks Holdings Inc	-32.81%	-7.15%	-83.33%	-95.11%	-28.16%
Regeneron Pharmaceuticals, Inc.	-5.98%	-39.7%	-31.49%	-3.13%	46.48%
Beone Medicines Ltd	-1.33%	25.17%	63.71%	24.48%	94.93%
Vertex Pharmaceuticals Incorporated	3.92%	9.39%	20.95%	99.92%	125.52%
Alnylam Pharmaceuticals, Inc.	13.07%	4.23%	86.32%	73.08%	183.51%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ginkgo Bioworks Holdings Inc	NA	NA	NA	0.0	-0.6	-0.2	NA	13.17
Regeneron Pharmaceuticals, Inc.	17.27	17.27	0.98	42.64	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.43	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.71	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ginkgo Bioworks Holdings Inc	Sell	$416.1M	-28.16%	NA	-240.94%
Regeneron Pharmaceuticals, Inc.	Buy	$72.4B	46.48%	17.27	31.07%
Beone Medicines Ltd	NA	$29.6B	94.93%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$131.0B	125.52%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$36.7B	183.51%	NA	-12.37%

Ginkgo Bioworks Dividend announcements

Ginkgo Bioworks Earnings
Ginkgo Bioworks’s price-to-earnings ratio stands at None

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Organization	Ginkgo Bioworks
Employees	834
CEO	Dr. Jason Kelly Ph.D.
Industry	Healthcare

Management People of Ginkgo Bioworks

Name	Title
Dr. Jason Kelly Ph.D.	Founder, CEO & Director
Dr. Reshma P. Shetty	Founder, President, COO & Director
Mr. Mark E. Dmytruk	Chief Financial Officer
Mr. Thomas Knight Jr.	Founder
Mr. Austin Che Ph.D.	Founder, Head of Strategy & Treasurer
Mr. Bartholomew Canton Ph.D.	Founder, CTO & Secretary
Mr. Steven P. Coen CPA	Chief Accounting Officer
Ms. Karen Tepichin	General Counsel & Secretary
Ms. Samantha Sutton	Head of People
Mr. Joshua Dunn	Head of Design

Important FAQs about investing in DNA Stock from India :

What is Ginkgo Bioworks share price today?

Ginkgo Bioworks share price today stands at $7.27, Open: $7.00 ; Previous Close: $7.17 ; High: $7.37 ; Low: $6.93 ; 52 Week High: $48.00 ; 52 Week Low: $5.26.

The stock opens at $7.00, after a previous close of $7.17. The stock reached a daily high of $7.37 and a low of $6.93, with a 52-week high of $48.00 and a 52-week low of $5.26.

Can Indians buy Ginkgo Bioworks shares?

Yes, Indians can invest in the Ginkgo Bioworks (DNA) from India.

With INDmoney, you can buy Ginkgo Bioworks at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ginkgo Bioworks at zero transaction cost.

How can I buy Ginkgo Bioworks shares from India?

It is very easy to buy Ginkgo Bioworks from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ginkgo Bioworks (DNA) be purchased?

Yes, you can buy fractional shares of Ginkgo Bioworks with INDmoney app.

What are the documents required to start investing in Ginkgo Bioworks stocks?

To start investing in Ginkgo Bioworks, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.